A limiting factor in organic solar cells (OSCs) is the incomplete absorption in the thin absorber layer. One concept to enhance absorption is to apply an optical cavity design. In this study, the performance of an OSC with cavity is evaluated. By means of a comprehensive energy yield (EY) model, the improvement is demonstrated by applying realistic sky irradiance, covering a wide range of incidence angles. The relative enhancement in EY for different locations is found to be 11-14% compared to the reference device with an indium tin oxide front electrode. The study highlights the improved angular light absorption as well as the angular robustness of an OSC with cavity.

Download full-text PDF

Source
http://dx.doi.org/10.1364/OE.404969DOI Listing

Publication Analysis

Top Keywords

angular light
8
energy yield
8
organic solar
8
solar cells
8
optical cavity
8
osc cavity
8
numerical study
4
study angular
4
light trapping
4
trapping energy
4

Similar Publications

The substantia nigra pars compacta (SNc), one of the main dopaminergic nuclei of the brain, exerts a regulatory function on the basal ganglia circuitry via the nigro-striatal pathway but its possible dopaminergic innervation of the thalamus has been only investigated in non-human primates. The impossibility of tract-tracing studies in humans has boosted advanced MRI techniques and multi-shell high-angular resolution diffusion MRI (MS-HARDI) has promised to shed more light on the structural connectivity of subcortical structures. Here, we estimated the possible dopaminergic innervation of the human thalamus via an MS-HARDI tractography of the SNc in healthy human young adults.

View Article and Find Full Text PDF

Early-onset Alzheimer's disease constitutes ∼5-10% of Alzheimer's disease. Its clinical characteristics and biomarker profiles are not well documented. To compare the characteristics covering clinical, neuropsychological and biomarker profiles between patients with early- and late-onset Alzheimer's disease, we enrolled 203 patients (late-onset Alzheimer's disease = 99; early-onset Alzheimer's disease = 104) from a Chinese hospital-based cohort, the Shanghai Memory Study.

View Article and Find Full Text PDF

Gabapentin impairs visual development in zebrafish via retinal apoptosis and thyroid disruption.

J Hazard Mater

January 2025

School of Environmental Science and Engineering, Nanjing Tech University, Jiangsu 211816, China; Sino-Portuguese Joint International Laboratory of Aquatic Toxicology, Nanjing Tech University, 30 South Puzhu Road, Nanjing, Jiangsu Province 211816, China. Electronic address:

Gabapentin (GBP), a pharmaceutical widely used for seizures and neuropathic pain, has emerged as a contaminant in global aquatic environments, raising concerns about its ecological impact. This study investigated the effects of environmentally relevant concentrations of GBP (0, 1, 10, 1000 μg/L) on visual development in zebrafish (Danio rerio). Behavioral assays showed that GBP exposure enhanced light sensitivity, as indicated by a significant increase in total travel distance (TTD) in all exposure groups compared to controls.

View Article and Find Full Text PDF

Optical vortex beams carrying orbit angular momentum have attracted significant attention recently. Perfect vortex beams, characterized by their topological charge-independent intensity profile, have important applications in enhancing communication capacity and optimizing particle manipulation. In this paper, metal-insulator-metal copper-coin type reflective metasurfaces are proposed to generate perfect composite vortex beams in X-band.

View Article and Find Full Text PDF

Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity.

Mult Scler Relat Disord

January 2025

Department of Neurology, School of Medicine, Washington University in St. Louis, 660 South Euclid Avenue, St Louis, MO 63110, USA. Electronic address:

Background: Prognostic biomarkers at multiple sclerosis (MS) onset to predict disease severity may help guide initial therapy selection for people with MS. Over 20 disease-modifying treatments (DMTs) of varying levels of risk and efficacy now exist. The ability to predict MS severity would help to identify those patients at higher risk where a highly effective, but potentially risky, therapy would be optimal.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!